MOSCOW, 7 April (BelTA) – The joint production of vaccines is to be included in the pharmaceutical plan of the Eurasian Economic Union, the press service of the Eurasian Economic Commission (EEC) told BelTA citing Tigran Harutyunyan, Deputy Director of the EEC Industrial Policy Department.
Tigran Harutyunyan took part in the panel session to discuss the EAEU pharmaceutical industry response to the coronavirus pandemic. The session was held on the sidelines of the Innoprom international exhibition in Uzbekistan. Tigran Harutyunyan informed that the EEC is developing an action plan to increase the stocks of essential medicines and pharmaceutical substances in the EAEU countries. The plan is one of the fundamental documents in the works by the EEC Industrial Policy Department. It is designed to ensure that the EAEU's demand for medicines will be fully met. According to the EEC representative, there are plans to include joint vaccine production into this plan. This idea is vigorously supported by representatives of the EAEU countries at all levels.
“The production of the Sputnik V vaccine has already been launched in Belarus and Kazakhstan in cooperation with the Russian Direct Investment Fund. The participation of Armenia and Kyrgyzstan in the joint production of the vaccine is also under discussion,” Tigran Harutyunyan said.
The press service recalled that the draft plan had been worked out by the commission with participation of authorized government agencies and businesses of the EAEU states. “Given the high social importance of the issue, a decision was made to submit it for approval to the heads of government of the EAEU countries. The document is to be sent to the Eurasian Intergovernmental Council at the end of this year,” the EEC press service added.
